Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.06.2017 | Case report

Rivaroxaban

Acute tubular necrosis and gastrointestinal bleeding: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Tiwari M, et al. Disastrous complication of direct factor Xa inhibitor in post-acute kidney injury (AKI). Blood Purification 43: 276-277, No. 1-3, Mar 2017. Available from: URL: http://doi.org/10.1159/000454962 [abstract] - USA Tiwari M, et al. Disastrous complication of direct factor Xa inhibitor in post-acute kidney injury (AKI). Blood Purification 43: 276-277, No. 1-3, Mar 2017. Available from: URL: http://​doi.​org/​10.​1159/​000454962 [abstract] - USA
Metadaten
Titel
Rivaroxaban
Acute tubular necrosis and gastrointestinal bleeding: case report
Publikationsdatum
01.06.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-31733-5

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Cyclophosphamide

Case report

Warfarin

Case report

Exemestane

Case report

Lamotrigine

Case report

Multiple drugs